Tarsus to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon [Yahoo! Finance]
Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon
Insider Returns Down To US$166k As Tarsus Pharmaceuticals' Stock Dips 14% [Yahoo! Finance]
Tarsus Pharmaceuticals (TARS) Upgraded to Buy: Here's Why [Yahoo! Finance]